Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-26 Purchase |
2023-06-27 4:10 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
1,608,000 | $0.64066 | $1,030,179 | 0 (Indirect Direct) |
View |
| 2023-06-15 Purchase |
2023-06-20 4:04 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
8,160 | $3.8779 | $31,644 | 1,608,000 (Indirect Direct) |
View |
| 2023-06-12 Purchase |
2023-06-14 4:14 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
16,899 | $3.7653 | $63,629 | 1,599,840 (Indirect Direct) |
View |
| 2023-06-07 Purchase |
2023-06-09 4:24 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
14,426 | $3.9124 | $56,440 | 1,582,941 (Indirect Direct) |
View |
| 2023-05-31 Purchase |
2023-06-02 4:22 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
844 | $2.87 | $2,422 | 1,568,515 (Indirect Direct) |
View |
| 2023-05-25 Purchase |
2023-05-30 4:27 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
2,671 | $2.7944 | $7,464 | 1,567,671 (Indirect Direct) |
View |
| 2023-05-24 Purchase |
2023-05-24 4:15 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
9,000 | $2.9796 | $26,816 | 1,565,000 (Indirect Direct) |
View |
| 2023-05-18 Purchase |
2023-05-22 4:30 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
26,621 | $3.3572 | $89,372 | 1,556,000 (Indirect Direct) |
View |
| 2023-05-12 Purchase |
2023-05-16 5:23 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
4,379 | $2.5135 | $11,007 | 1,529,379 (Indirect Direct) |
View |
| 2023-05-04 Purchase |
2023-05-08 4:10 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
25,000 | $2.7746 | $69,365 | 1,525,000 (Indirect Direct) |
View |
| 2023-04-25 Purchase |
2023-04-27 4:07 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
7,500 | $2.9898 | $22,423 | 1,500,000 (Indirect Direct) |
View |
| 2023-04-20 Purchase |
2023-04-24 4:32 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
17,500 | $3.0669 | $53,672 | 1,492,500 (Indirect Direct) |
View |
| 2023-04-17 Purchase |
2023-04-18 4:08 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
25,000 | $2.955 | $73,874 | 1,475,000 (Indirect Direct) |
View |
| 2023-04-10 Purchase |
2023-04-11 4:51 pm |
Avalo Therapeutics Inc. | AVTX | Caissa Capital Management ltd. 10% Owner |
56,329 | $2.5301 | $142,516 | 1,450,000 (Indirect Direct) |
View |